Calcium acetate + Magnesium carbonate interactions
Checked as Calcium acetate + Magnesium carbonate in this data source.
Full monograph for Calcium acetate + Magnesium carbonateCheck it against another medicine
Medicines
230 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Erdafitinibvia Magnesium carbonate, Calcium acetate | Major | Others | Coadministration with agents that can alter serum phosphate levels may affect the initial dosage determination of erdafitinib. The mechanism appears to be…2 documented mechanisms | 1 sources — open the full entry |
| Gefitinibvia Magnesium carbonate | Major | Absorption | Coadministration with drugs that elevate gastric pH such as H2-receptor antagonists and antacids may decrease the plasma concentrations of gefitinib. According… | 5 sources — open the full entry |
| Selpercatinibvia Magnesium carbonate | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of selpercatinib and reduce its concentrations in… | 2 sources — open the full entry |
| Sotorasibvia Magnesium carbonate | Major | Absorption | Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of sotorasib and reduce its concentrations in plasma. | 2 sources — open the full entry |
| Acalabrutinibvia Magnesium carbonate | Moderate | Absorption | INTERVAL: Coadministration with drugs that increase gastric pH may significantly decrease the oral bioavailability of acalabrutinib and reduce its… | 2 sources — open the full entry |
| Alendronic acidvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to…2 documented mechanisms | 9 sources — open the full entry |
| Alendronic Acid + Vitamin D3via Magnesium carbonate, Calcium acetate | Moderate | Absorption · Synergy | INTERVAL: Products containing aluminum, calcium, magnesium and other polyvalent cations such as antacids or vitamin with mineral supplements are likely to…3 documented mechanisms | 13 sources — open the full entry |
| Algae Calcium + Vitamin D3via Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxidevia Magnesium carbonate | Moderate | Synergy | The concomitant administration of magnesium salts with other magnesium-containing preparations such as antacids or laxatives may increase the risk of magnesium… | 1 sources — open the full entry |
| Aluminium Hydroxide + Magnesium Hydroxide + Simethiconevia Magnesium carbonate | Moderate | Synergy | The concomitant administration of magnesium salts with other magnesium-containing preparations such as antacids or laxatives may increase the risk of magnesium… | 1 sources — open the full entry |
| Aluminium Oxide + Magnesium Trisilicatevia Magnesium carbonate | Moderate | Synergy | The concomitant administration of magnesium salts with other magnesium-containing preparations such as antacids or laxatives may increase the risk of magnesium… | 1 sources — open the full entry |
| Amlodipine Besilatevia Calcium acetate | Moderate | Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been… | 46 sources — open the full entry |
| Amlodipine Besilate + Atenololvia Magnesium carbonate, Calcium acetate | Moderate | Absorption · Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been…3 documented mechanisms | 60 sources — open the full entry |
| Amlodipine Besilate + Atorvastatinvia Calcium acetate | Moderate | Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been… | 46 sources — open the full entry |
| Amlodipine Besilate + Benazepril Hydrochloridevia Magnesium carbonate, Calcium acetate | Moderate | Absorption · Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been…2 documented mechanisms | 50 sources — open the full entry |
| Amlodipine Besilate + Olmesartan Medoxomilvia Calcium acetate | Moderate | Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been… | 46 sources — open the full entry |
| Amlodipine Besilate + Telmisartanvia Calcium acetate | Moderate | Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been… | 46 sources — open the full entry |
| Amlodipine Besilate + Valsartanvia Calcium acetate | Moderate | Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been… | 46 sources — open the full entry |
| Aspirinvia Magnesium carbonate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Aspirin + Dipyridamolevia Magnesium carbonate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Atenololvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Atenolol + Chlorthalidonevia Magnesium carbonate, Calcium acetate | Moderate | Absorption · Synergy | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…3 documented mechanisms | 29 sources — open the full entry |
| Atropine Sulfate (Injection)via Magnesium carbonate | Moderate | Absorption | INTERVAL: Concurrent administration of antacids or adsorbent antidiarrheal agents may decrease the oral bioavailability of atropine. | 1 sources — open the full entry |
| Azilsartan Medoxomil + Chlorthalidonevia Calcium acetate | Moderate | Synergy | Coadministration of thiazide diuretics with high dosages of calcium and/or vitamin D has been associated with reports of hypercalcemia in some patients… | 15 sources — open the full entry |
| Azithromycin DihydratebaseOphthalmicvia Magnesium carbonate | Moderate | Absorption | INTERVAL: The concomitant administration of aluminum or magnesium-containing antacids may reduce peak serum concentrations (Cmax) of oral azithromycin, but… | 1 sources — open the full entry |
| Baloxavir Marboxilvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | Coadministration with polyvalent cation-containing products may decrease the plasma concentrations and therapeutic efficacy of baloxavir. The proposed…2 documented mechanisms | 3 sources — open the full entry |
| Benzoic Acid + Salicylic Acidvia Magnesium carbonate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Betamethasone Dipropionate + Salicylic Acidvia Magnesium carbonate | Moderate | Excretion | Chronic administration of antacids may reduce serum salicylate concentrations in patients receiving large doses of aspirin or other salicylates. The mechanism… | 8 sources — open the full entry |
| Betaxolol Hydrochloridevia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Bimatoprost + Timololvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Bisacodylvia Magnesium carbonate | Moderate | Absorption | INTERVAL: By increasing gastric pH, antacids may reduce the resistance of the enteric coating of bisacodyl tablets, resulting in earlier release of bisacodyl… | 1 sources — open the full entry |
| Bisoprolol Fumaratevia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Bisoprolol Fumarate + Amlodipine Besilatevia Magnesium carbonate, Calcium acetate | Moderate | Absorption · Antagonism | Calcium-containing products may decrease the effectiveness of calcium channel blockers by saturating calcium channels with calcium. Calcium chloride has been…3 documented mechanisms | 60 sources — open the full entry |
| Bisoprolol Fumarate + Hydrochlorothiazidevia Magnesium carbonate, Calcium acetate | Moderate | Absorption · Synergy | Coadministration of thiazide diuretics with high dosages of calcium and/or vitamin D has been associated with reports of hypercalcemia in some patients…3 documented mechanisms | 29 sources — open the full entry |
| Brimonidine Tartrate + Timolol Maleatevia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Brinzolamide + Timololvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Calcitriolvia Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium + Vitamin D3 + Multimineralvia Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Citrate + Calcitriolvia Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin C + Vitamin D3via Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3via Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Lactate Gluconate + Calcium Carbonate + Vitamin D3 + Multimineralsvia Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Calcium Phosphate [Milk source] + Vitamin D3via Magnesium carbonate | Moderate | Synergy | Use of magnesium-containing products with a vitamin D analog may increase the risk of hypermagnesemia, particularly in chronic renal dialysis patients, due to… | 4 sources — open the full entry |
| Candesartan Cilexetil + Hydrochlorothiazidevia Calcium acetate | Moderate | Synergy | Coadministration of thiazide diuretics with high dosages of calcium and/or vitamin D has been associated with reports of hypercalcemia in some patients… | 15 sources — open the full entry |
| Carbonyl Iron + Folic Acidvia Magnesium carbonate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfatevia Magnesium carbonate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carbonyl Iron + Folic Acid + Zinc Sulfate + Vitamin B Complex + Vitamin Cvia Magnesium carbonate | Moderate | Absorption | INTERVAL: The bioavailability of orally administered iron may be reduced by concomitant administration of antacids or other agents with acid-neutralizing… | 12 sources — open the full entry |
| Carvedilolvia Magnesium carbonate, Calcium acetate | Moderate | Absorption | INTERVAL: Concurrent administration with calcium salts may decrease the oral bioavailability of atenolol and possibly other beta-blockers. The exact mechanism…2 documented mechanisms | 14 sources — open the full entry |
| Cefdinirvia Magnesium carbonate | Moderate | Absorption | INTERVAL: Aluminum- or magnesium-containing antacids may interfere with the rate and extent of absorption of cefdinir. The mechanism has not been described but… | 1 sources — open the full entry |
| Cefditorenvia Magnesium carbonate | Moderate | Absorption | Coadministration with antacids or agents with acid-neutralizing effects may reduce the oral absorption and plasma concentrations of cefditoren pivoxil. | 2 sources — open the full entry |
Conditions
Conditions in which Calcium acetate + Magnesium carbonate needs care, as documented in this source.
Cardiac Conduction System Disease
MajorCalcium is involved in cardiac muscle contraction and electrical impulse conduction. Therapy with calcium salt formulations (particularly IV) should be administered cautiously to patients with cardiac disease. Patients receiving cardiac glycosides and concomitant IV calcium may experience arrhythmias. Therapy with IV calcium should be administered slowly and at reduced dosages in patients with cardiac disease.
2 sources
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation (2001):
Hyperphosphatemia
MajorElevated serum concentrations of calcium and phosphate can exceed the solubility level and result in calcium- phosphate precipitates that deposit in vascular and renal systems as well as other soft tissues of the body. Therapy with calcium should be administered with extreme caution in patients with hyperphosphatemia (hypoparathyroidism or severe renal impairment). Administration of oral calcium acetate or calcium carbonate, in addition to providing calcium, complexes phosphates within the GI tract. These complexes are eliminated in the feces. Clinical monitoring of serum calcium and phosphate concentrations is necessary.
2 sources
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation (2001):
Kidney Diseases
MajorAbsorption of oral calcium formulations may be altered and elimination of calcium by the kidney decreased with renal impairment. Hyperphosphatemia occurs during renal failure. Calcium acetate or calcium carbonate, in addition to providing calcium, complexes phosphates within the GI tract. Calcium carbonate can partially correct metabolic acidosis associated with chronic renal failure. Clinical monitoring of renal function and serum calcium and phosphate concentrations is necessary.
2 sources
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation (2001):
Malabsorption Syndromes
MajorCalcium is absorbed from the intestinal tract by active transport and passive diffusion. Malabsorption syndromes (celiac disease, GI resection), deficiency of vitamin D, parathyroid hormone, or calcitonin, or an alkaline gastric pH (achlorhydria, carbonate or phosphate salts) can decrease the absorption of oral formulations of calcium. Calcium is available in oral and parenteral formulations.
2 sources
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation (2001):
Sarcoidosis
MajorHypercalciuria, with or without hypercalcemia, may occasionally occur in patients with sarcoidosis. Elevated calcium levels may result from increased intestinal absorption of calcium, which is related to the extrarenal production of vitamin D by mononuclear phagocytes present within the sarcoid granuloma. Therapy with calcium salts should be administered cautiously and only if necessary in patients with sarcoidosis.
3 sources
- "Product Information. Posture (calcium phosphate, tribasic)." Whitehall-Robbins
- "Product Information. Neo-Calglucon (calcium glubionate)." Sandoz Pharmaceuticals Corporation (2001):
- Braunwald E, Hauser SL, Kasper DL, Fauci AS, Isselbacher KJ, Longo DL, Martin JB, eds., Wilson JD "Harrison's Principles of Internal Medicine." New York, NY: McGraw-Hill Health Professionals Division (1998):
Therapeutic duplication
Drug classes that overlap with Calcium acetate + Magnesium carbonate, so taking both doubles up the same effect. This source publishes no per-row citations for duplication.
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Nu-mag
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Suprep bowel prep kit
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Sutab
magnesium
The recommended maximum number of medicines in the 'magnesium' category to be taken concurrently is usually one.Your list includes two medicines belonging to the 'magnesium' category.
Example product in the source data (US market): Prepopik